## Abstract We present a general Bayesian framework for cost‐effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mea
✦ LIBER ✦
MI4: A FRAMEWORK FOR COST-EFFECTIVENESS ANALYSIS FROM CLINICAL TRIAL DATA
✍ Scribed by A O'Hagan; JW Stevens
- Book ID
- 118612990
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 59 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A framework for cost-effectiveness analy
✍
Anthony O'Hagan; John W. Stevens
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 262 KB
👁 1 views
Cost–effectiveness analysis of local, re
✍
P. Nordin; H. Zetterström; P. Carlsson; E. Nilsson
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 177 KB
👁 2 views
A cost-effectiveness clinical decision a
✍
I.-M. Wieselgren; E. Lindström; L. Lindström; L. Jönsson
📂
Article
📅
1999
🏛
Elsevier Science
🌐
English
⚖ 139 KB
A framework for incorporating cost-effec
✍
James Mason; Martin Eccles; Nick Freemantle; Michael Drummond
📂
Article
📅
1999
🏛
Elsevier Science
🌐
English
⚖ 123 KB
Stratified cost-effectiveness analysis:
✍
Douglas Coyle; Martin J. Buxton; Bernie J. O'Brien
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 126 KB
👁 1 views
## Abstract The cost‐effectiveness of new health care technologies is conditional upon who receives __what__ therapy and under __what__ circumstances. Understanding this heterogeneity in cost‐effectiveness, health care payers often limit reimbursement of therapies to a more restrictive sub‐group of
HM4 HOW ROBUST IS COST-EFFECTIVENESS RAT
✍
K Noyes; RG Holloway; AW Dick
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 70 KB